NCT03299855View on ClinicalTrials.gov

MoCA vs. MMS: Which Tool to Detect Cognitive Disorders in Oncogeriatric?

NACompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

October 13, 2017

Primary Completion Date

October 13, 2023

Study Completion Date

October 13, 2023

Conditions
Neoplasms
Interventions
OTHER

Passation of neuropsychological test

Passation of MoCA and MMS tests associated with neuropsychological test

Trial Locations (6)

Unknown

Centre François Baclesse, Caen

CHU, Caen

CH, Cherbourg

Ch Compiegne, Compiègne

Centre Henri Becquerel, Rouen

Centre Hospitalier, Saint-Lô

All Listed Sponsors
collaborator

UCOG (Unite de coordination en Onco-Gériatrie)

UNKNOWN

lead

Centre Francois Baclesse

OTHER

NCT03299855 - MoCA vs. MMS: Which Tool to Detect Cognitive Disorders in Oncogeriatric? | Biotech Hunter | Biotech Hunter